Refine your search:     
Report No.
 - 

Stability of $$^{186}$$Re- and $$^{188}$$Re-DMSAs and removal of impurity in the product

Komoto, Kazuki*; Nogawa, Norio*; Sato, Jun*; Makide, Yoshihiro*; Morikawa, Naotake*; Hashimoto, Kazuyuki; Sorita, Takami

Complex compound of $$^{186}$$Re and $$^{188}$$Re with meso-2,3-dimercaptosuccinic acid (DMSA) is expected to be effective against cancerous disease. This compound is synthesized with high radiochemical yield by use of SnCl$$_{2}$$ as reducing reagent. However, the product contains a large amount of SnCl$$_{2}$$ which is harmful to human body. The removal of tin impurity was tested with cation exchange resin. $$^{186}$$Re-DMSA complex was also obtained with high radiochemical yield by use of other harmless reducing agents (L-ascorbic acid, Na$$_{2}$$SO$$_{3}$$, H$$_{3}$$PO$$_{3}$$). Synthesized $$^{186}$$Re-DMSA by use of SnCl$$_{2}$$ was stable in sodium acetate buffer for 5 hours, while survival amount of $$^{186}$$Re-DMSA synthesized by other reducing agents decreased in a short time.

Accesses

:

- Accesses

InCites™

:

Altmetrics

:

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.